#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Postprandial hypoglycaemia Mantle cell lymphoma refractory Andersen-Tawil syndrome Richter's syndrome Soft tissue necrosis Adrenoleukodystrophy Thymic carcinoma Chronic graft versus host disease in skin Liver transplant rejection Mitochondrial encephalomyopathy Osteosarcoma metastatic Mitochondrial myopathy Acute graft versus host disease in liver Transferrin decreased More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Mitochondrial myopathy Behcet’s syndrome Lymphatic malformation – Basic Information Medulloblastoma – Life with Disease Hypereosinophilic syndrome – Basic Information Combined immunodeficiency – Basic Information Primary hyperoxaluria – Basic Information Angiosarcoma Ewing’s sarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oditrasertib Ly4100511 Ficlatuzumab Osimertinib Ibuprofen Sodium Dihydrate Other Immunosuppressants REGN7999 Hydroxyzine Hydrochloride Palonosetron Hydrochloride Methylprednisolone Acetate Pantoprazole Entecavir Satoreotide Tetraxetan Dolutegravir Ribitol Betula Alba Pollen Extract Immunglobulin Wt1 Mrna Dc Eplerenone Collagenase More therapies…

    Learn about Your Condition

    Microvillous inclusion disease BK virus infection Hodgkin's disease recurrent Peritoneal dialysis Hepatitis D Habitual abortion Penile squamous cell carcinoma Phenylketonuria Femoral neck fracture Type V hyperlipidaemia Follicular lymphoma stage III Pelvic venous thrombosis Soft tissue sarcoma Delayed graft function Septic shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France

  • Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Bedaquiline
    • Clofazimine
    • Linezolid
    France

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin Sodium
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    France

  • Study comparing 3-week versus 6-week antibiotic treatment for patients with drained pyogenic liver abscess

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cilastatin
    • Daptomycin
    • Imipenem
    France

  • Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    • Pneumonia bacterial
    • Pneumonia
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftazidime
    France
Previous Page
1 … 25 26 27 28 29 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!